https://www.octapharma.ca/en/octapharma https://www.octapharma.ca/en/octapharma/pharmacovigilance-data-privacy-statement https://www.octapharma.ca/en/news https://www.octapharma.ca/en/octapharma/contact https://www.octapharma.ca/en/news/press-release/2020/fda-approval-of-updated-nuwiq-to-include-immunogenicity-data-in-pups https://www.octapharma.ca/en/news/our-employees/2022/building-on-strong-values https://www.octapharma.ca/en/octapharma/privacy-statement https://www.octapharma.ca/en/news/corporate-news/2019/celebrating-our-milestones https://www.octapharma.ca/en/news/corporate-news/2022/earning-donors-trust https://www.octapharma.ca/en/news/corporate-news/2022/securing-our-future-by-boosting-capacity https://www.octapharma.ca/en/news/corporate-news/2022/the-essential-role-of-pbm-during-the-pandemic https://www.octapharma.ca/en/news/corporate-news/2019/update-of-summary-of-product-characteristics-for-nuwiq https://www.octapharma.ca/en/news/press-release/2019/positive-results-for-fibryga-published-in-the-journal-of-thrombosis-and-haemostasis https://www.octapharma.ca/en/news/our-employees/2018/from-childhood-dream-to-research-team https://www.octapharma.ca/en/octapharma/legal-statement https://www.octapharma.ca/en/news/press-release/2019/final-results-from-the-nuprotect-study-demonstrating-efficacy-of-nuwiq https://www.octapharma.ca/en/news/our-employees/2018/persistence-and-ingenuity-pays-off https://www.octapharma.ca/en/news/corporate-news/2019/octapharma-group-reports-strong-results-for-2018 https://www.octapharma.ca/en/news/innovation-and-science/2018/timely-help-for-critically-ill-patients https://www.octapharma.ca/en/news/corporate-news/2018/octapharma-group-publishes-2017-annual-results https://www.octapharma.ca/en/news/press-release/2024/canadian-study-explores-preoperative-4f-pcc-for-managing-bleeding-risks-in-af-patients-on-fxa-inhibitors https://www.octapharma.ca/en/news/press-release/2024/wilate-is-now-approved-in-canada-for-prophylaxis-in-von-willebrand-disease https://www.octapharma.ca/en/news/patient-stories/2020/take-one-day-at-a-time-and-live https://www.octapharma.ca/en/news/innovation-and-science/2018/low-inhibitor-rate-with-octanate-in-previously-untreated-patients https://www.octapharma.ca/en/careers https://www.octapharma.ca/en/therapies/product-overview https://www.octapharma.ca/en/news/our-employees/2018/medicine-as-an-art-form https://www.octapharma.ca/en/news/press-release/2019/final-results-from-the-nuprotect-study https://www.octapharma.ca/en/news/corporate-news/2018/octapharma-share-promising-preclinical-data-for-subq-8 https://www.octapharma.ca/en/news/corporate-news/2017/octapharma-group-publishes-2016-annual-results https://www.octapharma.ca/en/news/corporate-news/2019/new-data-on-haemophilia-a-or-von-willebrand-disease-at-isth-2019 https://www.octapharma.ca/en/news/press-release/2021/akron-biotech-signs-exclusive-global-agreement-with-octapharma https://www.octapharma.ca/en/news/patient-stories/2020/winners-never-quit https://www.octapharma.ca/en/news/corporate-news/2018/octapharma-to-build-new-multi-use-venue https://www.octapharma.ca/en/news/corporate-news/2019/update-on-the-development-of-subq-8-isth-2019 https://www.octapharma.ca/en/about-us/who-we-are https://www.octapharma.ca/en/news/innovation-and-science/2018/octapharma-present-new-data-on-the-benefits-of-nuwiq https://www.octapharma.ca/en/news/corporate-news/2017/octapharma-activities-prominent-at-the-upcoming-2017-isth-congress https://www.octapharma.ca/en/news/press-release/2019/fibryga-receives-european-label-extension-to-treat-acquired-fibrinogen-deficiency-afd https://www.octapharma.ca/en/news/our-employees/2018/using-big-data-to-improve-lives https://www.octapharma.ca/en/news/press-release/2022/inesss-recommends-the-addition-of-fibryga-to-the-blood-product-list-of-quebec https://www.octapharma.ca/en/news/patient-stories/2022/dermatomyositis-diagnosis https://www.octapharma.ca/en/news/patient-stories/2022/living-with-von-willebrand-disease https://www.octapharma.ca/en/news/patient-stories/2022/pbm-and-use-of-factor-concentrates-separation-of-conjoined-twins https://www.octapharma.ca/en/news/patient-stories/2022/successful-treatment-of-dermatomyositis https://www.octapharma.ca/en/news/press-release/2021/octapharma-to-demonstrate-ongoing-commitment-at-the-14th-eahad-annual-congress https://www.octapharma.ca/en/news/patient-stories/2018/engaging-with-patients https://www.octapharma.ca/en/news/corporate-news/2019/new-data-isth-2019 https://www.octapharma.ca/en/news/innovation-and-science/2018/octapharma-announces-approval-of-new-nuwiq-product-strengths https://www.octapharma.ca/en/news/press-release/2019/octapharma-announces-publication-of-data-on-fibryga https://www.octapharma.ca/en/news/corporate-news/2017/octapharma-symposium-at-isth-berlin https://www.octapharma.ca/en/news/our-employees/2018/an-eye-for-detail https://www.octapharma.ca/en/plasma https://www.octapharma.ca/en/news/press-release/2025/jama-publishes-fares-ii-study-confirming-the-superior-hemostatic-efficacy-of-octaplex-4f-pcc-over-frozen-plasma-in-cardiac-surgery https://www.octapharma.ca/en/news/press-release/2024/octaplas-lg-powder-for-solution-for-infusion-making-a-vital-contribution-to-the-health-of-canadian-soldiers https://www.octapharma.ca/en/contact https://www.octapharma.ca/en/news/innovation-and-science/2022/patient-blood-management-a-new-standard-of-care https://www.octapharma.ca/en/news/corporate-news/2021/donating-plasma-and-saving-lives https://www.octapharma.ca/en/news/patient-stories/2021/facing-vwd-during-covid-19-as-both-a-nurse-and-patient https://www.octapharma.ca/en/news/innovation-and-science/2021/patient-blood-management-a-new-standard-of-care https://www.octapharma.ca/en/news/press-release/2020/octapharma-reports-positive-data-from-octagam-usage-in-critically-ill-covid-19-patients https://www.octapharma.ca/en/news/innovation-and-science/2020/patient-blood-management https://www.octapharma.ca/en/news/patient-stories/2016/blood-is-essential-for-the-wellbeing-of-everyone https://www.octapharma.ca/en/ https://www.octapharma.ca/en/news/patient-stories/2017/octapharma-usa-sponsors-hope-ignites-stories-to-inspire https://www.octapharma.ca/en/news/our-employees/2017/bringing-new-optimal-therapies https://www.octapharma.ca/en/news/our-employees/2018/getting-our-medicines-to-patients https://www.octapharma.ca/en/news/innovation-and-science/2017/isth-2017-berlin-octapharma-presents-exciting-nuwiq-data https://www.octapharma.ca/en/about-us https://www.octapharma.ca/en/about-us/diseases-and-therapies https://www.octapharma.ca/en/news/patient-stories/2018/real-hope-for-brandon https://www.octapharma.ca/en/therapies https://www.octapharma.ca/en/news/innovation-and-science/2018/octapharma-receives-swissmedic-approval-for-fibryga https://www.octapharma.ca/en/news/corporate-news/2021/financial-review-2020 https://www.octapharma.ca/en/news/patient-stories/2021/cancer-was-not-part-of-the-plan https://www.octapharma.ca/en/news/press-release/2020/isth2020-results https://www.octapharma.ca/en/contact/medical-information https://www.octapharma.ca/en/careers/opportunities-at-octapharma https://www.octapharma.ca/en/news/our-employees/2017/inspecting-finished-products https://www.octapharma.ca/en/news/innovation-and-science/2018/new-canadian-study-to-improve-eradication-of-inhibitors https://www.octapharma.ca/en/about-us/who-we-are/leadership https://www.octapharma.ca/en/news/innovation-and-science/2017/octapharma-underlines-strong-commitment-to-haemophilia-a-patients https://www.octapharma.ca/en/news/patient-stories/2017/octapharma-usa-sponsors-nhf-annual-meeting https://www.octapharma.ca/en/about-us/diseases-and-therapies/haematology https://www.octapharma.ca/en/news/patient-stories/2018/strong-commitment-for-the-two-brothers-from-estonia https://www.octapharma.ca/en/news/our-employees/2016/saving-lives https://www.octapharma.ca/en/news/patient-stories/2016/one-in-ten-patients https://www.octapharma.ca/en/careers/job-detail/ea-to-gm-and-office-manager https://www.octapharma.ca/en/news/corporate-news/2021/letter-from-our-chairman-annual-report-2020 https://www.octapharma.ca/en/news/patient-stories/2021/reaching-a-community-in-need-helping-patients-with-pans https://www.octapharma.ca/en/news/press-release/2020/fibryga-receives-health-canada-approval-to-treat-acquired-fibrinogen-deficiency-in-surgical-settings https://www.octapharma.ca/en/contact/drug-safety https://www.octapharma.ca/en/therapies/production-process https://www.octapharma.ca/en/news/patient-stories/2017/octapharma-usa-grant-supports-mission-of-first-hemophiliac-to-climb-the-seven-summits-of-the-world https://www.octapharma.ca/en/news/patient-stories/2016/i-am-lucky-to-be-alive https://www.octapharma.ca/en/news/our-employees/2017/preserving-human-proteins https://www.octapharma.ca/en/careers/how-to-apply https://www.octapharma.ca/en/about-us/diseases-and-therapies/immunotherapy https://www.octapharma.ca/en/about-us/who-we-are/milestones https://www.octapharma.ca/en/news/innovation-and-science/2017/publication-of-clinical-data-demonstrating-low-immunogenicity-and-excellent-efficacy-of-nuwiq https://www.octapharma.ca/en/careers/job-detail/hr-generalist https://www.octapharma.ca/en/news/corporate-news/2021/committed-to-the-fight-against-covid-19 https://www.octapharma.ca/en/news/press-release/2020/octapharma-launches-phase-3-superiority-study-for-pediatric-acute-onset-neuropsychiatric-syndrome https://www.octapharma.ca/en/contact/contactform https://www.octapharma.ca/en/therapies/quality-and-safety https://www.octapharma.ca/en/news/patient-stories/2017/octapharma-donates-30-5-million-international-units-of-its-medicine https://www.octapharma.ca/en/news/our-employees/2017/investing-to-increase-capacity-and-automation https://www.octapharma.ca/en/about-us/diseases-and-therapies/critical-care https://www.octapharma.ca/en/about-us/research-and-development https://www.octapharma.ca/en/news/patient-stories/2016/there-is-always-time-in-life-for-an-adventure https://www.octapharma.ca/en/contact/canada-product-technical-complaints https://www.octapharma.ca/en/news/corporate-news/2021/ensuring-plasma-supplies-during-covid-19 https://www.octapharma.ca/en/about-us/our-locations https://www.octapharma.ca/en/news/our-employees/2017/purifying-products https://www.octapharma.ca/en/news/patient-stories/2016/it-is-as-if-a-big-hammer-falls-down-on-you https://www.octapharma.ca/en/news/patient-stories/2017/donors-like-my-father https://www.octapharma.ca/en/news/our-employees/2017/cultivating-factor-viii https://www.octapharma.ca/en/news/patient-stories/2017/donating-plasma https://www.octapharma.ca/en/news/patient-stories/2016/my-illness-has-given-me-the-will-to-live https://www.octapharma.ca/en/news/patient-stories/2016/when-i-am-dancing-i-feel-free https://www.octapharma.ca/en/news/our-employees/2017/validating-cleaning-methods https://www.octapharma.ca/en/news/our-employees/2017/getting-the-right-material https://www.octapharma.ca/en/news/patient-stories/2016/a-hyperactive-kid-with-haemophilia-is-a-dangerous-cocktail https://www.octapharma.ca/en/news/our-employees/2017/separating-plasma-proteins https://www.octapharma.ca/en/news/patient-stories/2016/the-tainted-blood-scandal-was-hugely-tragic-but-very-instructive- https://www.octapharma.ca/en/news/our-employees/2017/maintaining-the-cold-chain https://www.octapharma.ca/en/news/patient-stories/2016/i-never-let-haemophilia-dictate-how-i-live-my-life https://www.octapharma.ca/en/news/our-employees/2017/around-the-clock-production https://www.octapharma.ca/en/news/our-employees/2017/documenting-the-complete-history-of-every-production-batch https://www.octapharma.ca/en/news/patient-stories/2016/i-want-to-be-a-superhero https://www.octapharma.ca/en/news/our-employees/2017/performing-analytical-methods https://www.octapharma.ca/en/news/patient-stories/2016/haemophilia-is-just-a-part-of-who-my-sons-are https://www.octapharma.ca/en/news/our-employees/2017/detecting-viruses-early https://www.octapharma.ca/en/news/our-employees/2017/ensuring-safety-and-suitability-of-donors https://www.octapharma.ca/en/news/our-employees/2017/controlling-the-plasma https://www.octapharma.ca/en/news/our-employees/2017/research-that-helps-people